RYAN ELDREDGE WILCOX, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 55831
Category
Osteopathic Medicine
Type
Hematology & Oncology
License number
Minnesota 106315
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Professional information
Dr. Ryan E Wilcox, Rochester MN - MD (Doctor of Medicine)
Specialties:
Hematology, Hematology & Oncology
Age:
47
Address:
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
INTERMOUNTAIN MEDICAL CENTER OUTPATIENT CLINIC
5121 Cottonwood St STE 300, Salt Lake City 84107
(801) 507-3310 (Phone), (801) 507-3350 (Fax)
(507) 284-2511 (Phone)
INTERMOUNTAIN MEDICAL CENTER OUTPATIENT CLINIC
5121 Cottonwood St STE 300, Salt Lake City 84107
(801) 507-3310 (Phone), (801) 507-3350 (Fax)
Conditions:
Chronic Myeloid Leukemia (CML), Myeloproliferative Disorders
Languages:
English
Education:
Medical School
University of Utah
Graduated: 2009
University of Utah
Graduated: 2009
Dr. Ryan A Wilcox, Rochester MN - MD (Doctor of Medicine)
Specialties:
Hematology
Address:
Mayo Clinic Gastroenterology & Hepatology
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Languages:
English
Education:
Medical School
Mayo Medical School
Graduated: 2002
Mayo Medical School
Graduated: 2002
Depleting Immunosuppressive Monocytes Within A Mammal
US Patent:
2012017, Jul 5, 2012
Filed:
Sep 7, 2010
Appl. No.:
13/394787
Inventors:
Ryan A. Wilcox - Rochester MN, US
Thomas E. Witzig - Rochester MN, US
Thomas E. Witzig - Rochester MN, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
A61K 39/395, A61P 35/00, A61P 29/00, A61P 37/04
US Classification:
4241341
Abstract:
This document provides methods and materials involved in depleting immunosuppressive monocytes (e.g., CD14/DR or CD14/DRmonocytes) within a mammal. For example, methods and materials involved in using a CD2 binding molecule (e.g., alefacept) to deplete immunosuppressive monocytes within a mammal (e.g., a human) are provided.